Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-09

FDA Approved: TELMISARTAN — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approves a supplemental application for telmisartan from Ascend Laboratories, LLC, authorizing continued marketing of the generic ARB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)